ArticlePublished 2013
Glycogen Synthase Kinase 3andbeta; in Pancreatic Cancer and its Implications in Chemotherapy and Radiation Therapy
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Pancreatic cancer is a highly lethal disease with a poor prognosis characterized by local and systemic disease progression. Both radiation and chemotherapy play important roles in the management of this disease. However, in order to improve standard therapy many molecularly targeted agents are being developed. Glycogen synthase kinase 3β (GSK3β) participates in a multitude of cellular processes and is a newly proposed therapeutic target in pancreatic cancer. This review will discuss both the oncogenic and tumor suppressor functions of GSK3β in pancreatic cancer with an emphasis on the roles of GSK3β in tumor cell survival and sensitivity to radiation and chemotherapy.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Carcinogenesis & Mutagenesis
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Qiang Zhang”
- BylineArticles whose byline prints “Mahaveer S. Bhojani”
- BylineArticles whose byline prints “Edgar Ben-Josef”
- BylineArticles whose byline prints “Aaron C. Spalding”
- BylineArticles whose byline prints “Rork Kuick”
- BylineArticles whose byline prints “Yi Sun”
- BylineArticles whose byline prints “Meredith A. Morgan”